Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermal leishmaniasis and rifampicin.

R K Joshi1, P M Nambiar

  • 1Department of Dermatology, Al-Huwaylat Hospital, Jubail Industrial City, Saudi Arabia.

International Journal of Dermatology
|November 1, 1989
PubMed
Summary

Rifampicin effectively treated cutaneous leishmaniasis in 80% of patients. This well-tolerated drug offers a promising option for managing this skin infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulation of streptozotocin induced Type 1 diabetes mellitus in mouse model by Macrophage migration inhibitory factor-2 (MIF-2) homologue of human lymphatic filarial parasite, Wuchereria bancrofti.

Acta tropica·2024
Same author

Separation and purification using GO and r-GO membranes.

RSC advances·2022
Same author

[Medicaments and oral healthcare. Systematic review of the -literature assessing the effect of drugs on the salivary glands].

Nederlands tijdschrift voor tandheelkunde·2018
Same author

Extraordinary water adsorption characteristics of graphene oxide.

Chemical science·2018
Same author

Author Correction: Salinity stratification controlled productivity variation over 300 ky in the Bay of Bengal.

Scientific reports·2018
Same author

Tungiasis: Outbreak investigation of a zoonosis during overseas deployment.

Medical journal, Armed Forces India·2018

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cutaneous leishmaniasis is a parasitic skin infection with limited treatment options.
  • Rifampicin is an antibiotic with potential antileishmanial activity.

Purpose of the Study:

  • To evaluate the effectiveness and tolerance of rifampicin in treating cutaneous leishmaniasis.

Main Methods:

  • An uncontrolled study involving 15 patients with cutaneous leishmaniasis.
  • Treatment duration varied between 2 to 12 weeks.

Main Results:

  • Twelve out of 15 patients (80%) demonstrated a good clinical response.
  • Rifampicin was well-tolerated, with the only reported side effect being red urine discoloration.

Conclusions:

  • Rifampicin shows significant efficacy in treating cutaneous leishmaniasis.
  • The drug is a safe and viable therapeutic option for managing this condition.

Related Experiment Videos